MENU
+Compare
ALKS
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$29.75
Change
-$0.22 (-0.73%)
Capitalization
4.55B

ALKS Alkermes plc Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ALKS with price predictions
Dec 20, 2024

ALKS's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for ALKS moved out of overbought territory on December 10, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on ALKS as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALKS turned negative on December 17, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALKS broke above its upper Bollinger Band on December 04, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

ALKS moved above its 50-day moving average on November 22, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALKS advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 225 cases where ALKS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.784) is normal, around the industry mean (57.958). P/E Ratio (8.902) is within average values for comparable stocks, (89.727). ALKS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (2.779) is also within normal values, averaging (19.472).

View a ticker or compare two or three
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALKS is expected to report earnings to rise 3.19% to 75 cents per share on February 13

Alkermes plc ALKS Stock Earnings Reports
Q4'24
Est.
$0.75
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.04
Q1'24
Missed
by $0.16
Q4'23
Missed
by $0.23
The last earnings report on October 24 showed earnings per share of 73 cents, beating the estimate of 72 cents. With 4.64M shares outstanding, the current market capitalization sits at 4.55B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XDQQ34.310.26
+0.75%
Innovator Gr 100 Acltd ETF™ Quarterly
DBB19.740.11
+0.56%
Invesco DB Base Metals
DGS49.850.27
+0.54%
WisdomTree Emerging Markets SmCp Div ETF
XSHQ42.920.11
+0.26%
Invesco S&P SmallCap Quality ETF
AGIH24.65N/A
N/A
iShares Inflation Hdg U.S. Aggt Bd ETF

ALKS and Stocks

Correlation & Price change

A.I.dvisor tells us that ALKS and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALKS and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-0.87%
ACET - ALKS
30%
Poorly correlated
+5.78%
VTRS - ALKS
28%
Poorly correlated
+3.22%
COLL - ALKS
27%
Poorly correlated
-2.43%
AMPH - ALKS
26%
Poorly correlated
-0.63%
PAHC - ALKS
25%
Poorly correlated
-0.55%
More